Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | SORT1 | Q99523 | 3/20 | 0.37 |
| ▸ | PDE3B | Q13370 | 5/20 | 0.35 |
| ▸ | PDE3A | Q14432 | 5/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | CDC7 | O00311 | 2/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL181974 | 0.82 | NOTUM (0.67) | NOTUMLMNAMAPTSORT1GAA | |
| SCHEMBL452337 | 0.78 | NOTUM (0.68) | NOTUMMAPTSORT1PDE3BPDE3A | |
| SCHEMBL789358 | 0.78 | NOTUM (0.68) | NOTUMSORT1 | |
| SCHEMBL9782150 | 0.78 | NOTUM (1.00) | NOTUMLMNAMAPTSORT1PKM | |
| SCHEMBL22925624 | 0.78 | NOTUM (0.62) | NOTUM | |
| SCHEMBL11023401 | 0.74 | NOTUM (0.62) | NOTUMSORT1TP53 | |
| SCHEMBL20370831 | 0.74 | NOTUM (0.67) | NOTUMLMNAMAPTSORT1TP53 | |
| SCHEMBL14373829 | 0.74 | NOTUM (0.62) | NOTUMLMNAMAPTPKMGAA | |
| SCHEMBL11717156 | 0.73 | NOTUM (0.56) | NOTUMSORT1TP53 | |
| SCHEMBL8597250 | 0.70 | NOTUM (0.55) | NOTUMLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260049073-A1 | SPECTACLE LENS COMPRISING AN ORGANIC DYE | OAKLEY, INC. (US) | 2026-02-19 | — | — | US | disclosed |
| WO-2024226717-A1 | SPECTACLE LENS COMPRISING AN ORGANIC DYE | OAKLEY, INC. (US) | 2024-10-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049073-A1 | SPECTACLE LENS COMPRISING AN ORGANIC DYE | STRA6, TCOF1, CLIC1 | NOTUM 3324/4885LMNA 1842/4885MAPT 2539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.